The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Interaction Between Commensal Bacteria, Immune Response and the Intestinal Barrier in Inflammatory Bowel Disease
Open accessAbstract
In inflammatory bowel disease (IBD), intestinal mucosa cell and intestinal epithelial cell are severely damaged, and then their susceptibility to bacteria increases, so many commensal bacteria become pathogenic. The pathogenic commensal bacteria can stimulate a series of compensatory immune responses in the intestine. However, the immune response prevents the intestinal tract from restoring homeostasis, which in turn produces an indispensable inflammatory response. On the contrary, in IBD, the fierce inflammatory response contributes to the development of IBD. However, the effect of commensal bacteria on inflammation in IBD has not been clearly studied. Therefore, we further summarize the changes brought about by the changes of commensal bacteria to the inflammation of the intestines and their mutual influence. This article reviews the protective mechanism of commensal bacteria in healthy people and the mechanism of commensal bacteria and immune response to the destruction of the intestinal barrier when IBD occurs. The treatment and prevention of IBD are also briefly summarized.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
Self-citationNg, S. C., Shi, H. Y., Hamidi, N., Underwood, F. E., Tang, W., Benchimol, E. I., Panaccione, R., Ghosh, S., Wu, J. C. Y., Chan, F. K. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32448-0 · Cited by 6,087
Revised Estimates for the Number of Human and Bacteria Cells in the Body
Sender, R., Fuchs, S., & Milo, R. (2016) · PLOS Biology · doi:10.1371/journal.pbio.1002533 · Cited by 5,425
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173
Intestinal mucosal barrier function in health and disease
Turner, J. R. (2009) · Nature reviews. Immunology · doi:10.1038/nri2653 · Cited by 3,952 · cited 1×
“The human intestinal barrier is the first line of defense for the invasion of pathogenic microorganisms (9).”
BackgroundToll-like receptors and their crosstalk with other innate receptors in infection and immunity
Kawai, T., & Akira, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.006 · Cited by 3,658 · cited 1×
“After a large number of Proteobacteria pass through the mucosal barrier, pathogen-associated molecular patterns (PAMP), lipopolysaccharide and flagellin on the surface of the proteobacteria, are recognized by the toll-like receptors on the surface of dendritic cells (74, 75).”
BackgroundFormation of propionate and butyrate by the human colonic microbiota
Louis, P., & Flint, H. J. (2017) · Environmental Microbiology · doi:10.1111/1462-2920.13589 · Cited by 3,028
The global burden of IBD: from 2015 to 2025
Kaplan, G. G. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.150 · Cited by 2,639
Round, J. L., & Mazmanian, S. K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909122107 · Cited by 2,233
Louis, P., & Flint, H. J. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01514.x · Cited by 2,179
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
Chassaing, B., Koren, O., Goodrich, J. K., Poole, A. C., Srinivasan, S., Ley, R. E., & Gewirtz, A. T. (2015) · Nature · doi:10.1038/nature14232 · Cited by 2,055
Gut microbiota-derived metabolites as key actors in inflammatory bowel disease
Lavelle, A., & Sokol, H. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0258-z · Cited by 2,015
The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
Kostic, A. D., Xavier, R. J., & Gevers, D. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.009 · Cited by 1,789
Rivière, A., Selak, M., Lantin, D., Leroy, F., & De Vuyst, L. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00979 · Cited by 1,726
Kelly, C. J., Zheng, L., Campbell, E. L., Saeedi, B., Scholz, C. C., Bayless, A. J., Wilson, K. E., Glover, L. E., Kominsky, D. J., Magnuson, A., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.03.005 · Cited by 1,716
Induction of Protective IgA by Intestinal Dendritic Cells Carrying Commensal Bacteria
Macpherson, A. J., & Uhr, T. (2004) · Science · doi:10.1126/science.1091334 · Cited by 1,584
Inflammatory bowel disease: Pathogenesis
Zhang, Y.-Z. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i1.91 · Cited by 1,507
Johansson, M. E. V., Larsson, J. M. H., & Hansson, G. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006451107 · Cited by 1,452
Macia, L., Tan, J., Vieira, A. T., Leach, K., Stanley, D., Luong, S., Maruya, M., Ian McKenzie, C., Hijikata, A., Wong, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms7734 · Cited by 1,439
Png, C. W., Lindén, S. K., Gilshenan, K. S., Zoetendal, E. G., McSweeney, C. S., Sly, L. I., McGuckin, M. A., & Florin, T. H. J. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.281 · Cited by 1,364 · cited 2×
“However, the total abundance of mucus-degrading bacteria in IBD patients is increased significantly (49).”
BackgroundLymphokine Production by Human T Cells in Disease States
Romagnani, S. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.227 · Cited by 1,343
Fungal microbiota dysbiosis in IBD
Sokol, H., Leducq, V., Aschard, H., Pham, H.-P., Jegou, S., Landman, C., Cohen, D., Liguori, G., Bourrier, A., Nion-Larmurier, I., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-310746 · Cited by 1,314
Salt-responsive gut commensal modulates TH17 axis and disease
Wilck, N., Matus, M. G., Kearney, S. M., Olesen, S. W., Forslund, K., Bartolomaeus, H., Haase, S., Mähler, A., Balogh, A., Markó, L., et al. (2017) · Nature · doi:10.1038/nature24628 · Cited by 1,310
Pathophysiology of Inflammatory Bowel Diseases
Chang, J. T. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2002697 · Cited by 1,295
The indigenous gastrointestinal microflora
Berg, R. (1996) · Trends in Microbiology · doi:10.1016/0966-842x(96)10057-3 · Cited by 1,153 · cited 1×
“The gastrointestinal tract provides 150-200 m(2) of surface area for microorganisms (18), and about 10(13) bacteria are colonized, which is comparable to the number of human cells (19).”
BackgroundA Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease
Guan, Q. (2019) · Journal of Immunology Research · doi:10.1155/2019/7247238 · Cited by 1,065
Gut Microbiota and Immune System Interactions
Yoo, J., Groer, M., Dutra, S., Sarkar, A., & McSkimming, D. (2020) · Microorganisms · doi:10.3390/microorganisms8101587 · Cited by 1,032
Exploring Microbial Diversity and Taxonomy Using SSU rRNA Hypervariable Tag Sequencing
Huse, S. M., Dethlefsen, L., Huber, J. A., Welch, D. M., Relman, D. A., & Sogin, M. L. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000255 · Cited by 1,001
Fuchs, A., Vermi, W., Lee, J. S., Lonardi, S., Gilfillan, S., Newberry, R. D., Cella, M., & Colonna, M. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.010 · Cited by 907
Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD
Na, Y. R., Stakenborg, M., Seok, S. H., & Matteoli, G. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0172-4 · Cited by 900
Gut Microbial Metabolites Fuel Host Antibody Responses
Kim, M., Qie, Y., Park, J., & Kim, C. H. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.07.001 · Cited by 893 · cited 2×
“SCFAs activate and release IL-18 through inflammasomes to maintain the integrity of the intestinal epithelium (38).”
BackgroundThe microbiome and inflammatory bowel disease
Glassner, K. L., Abraham, B. P., & Quigley, E. M. M. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.11.003 · Cited by 837
New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD
Larabi, A., Barnich, N., & Nguyen, H. T. T. (2020) · Autophagy · doi:10.1080/15548627.2019.1635384 · Cited by 835
Interleukin-23 drives innate and T cell–mediated intestinal inflammation
Hue, S., Ahern, P., Buonocore, S., Kullberg, M. C., Cua, D. J., McKenzie, B. S., Powrie, F., & Maloy, K. J. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061099 · Cited by 823
IBD—what role do Proteobacteria play?
Mukhopadhya, I., Hansen, R., El-Omar, E. M., & Hold, G. L. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.14 · Cited by 810
The gut microbiota and inflammatory bowel disease
Matsuoka, K., & Kanai, T. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-014-0454-4 · Cited by 804
Host–microbiota interactions in inflammatory bowel disease
Caruso, R., Lo, B. C., & Núñez, G. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0268-7 · Cited by 780
Khan, I., Ullah, N., Zha, L., Bai, Y., Khan, A., Zhao, T., Che, T., & Zhang, C. (2019) · Pathogens · doi:10.3390/pathogens8030126 · Cited by 771
The Intermucosal Connection between the Mouth and Gut in Commensal Pathobiont-Driven Colitis
Kitamoto, S., Nagao-Kitamoto, H., Jiao, Y., Gillilland, M. G., Hayashi, A., Imai, J., Sugihara, K., Miyoshi, M., Brazil, J. C., Kuffa, P., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.048 · Cited by 680
Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease
Chu, H., Khosravi, A., Kusumawardhani, I. P., Kwon, A. H. K., Vasconcelos, A. C., Cunha, L. D., Mayer, A. E., Shen, Y., Wu, W.-L., Kambal, A., et al. (2016) · Science · doi:10.1126/science.aad9948 · Cited by 647
Ito, H., Takazoe, M., Fukuda, Y., Hibi, T., Kusugami, K., Andoh, A., Matsumoto, T., Yamamura, T., Azuma, J., & Nishimoto, N. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.012 · Cited by 636
Flint, H. J., Duncan, S. H., Scott, K. P., & Louis, P. (2007) · Environmental Microbiology · doi:10.1111/j.1462-2920.2007.01281.x · Cited by 635
Antibiotics as deep modulators of gut microbiota: between good and evil
Ianiro, G., Tilg, H., & Gasbarrini, A. (2016) · Gut · doi:10.1136/gutjnl-2016-312297 · Cited by 625
Coccia, M., Harrison, O. J., Schiering, C., Asquith, M. J., Becher, B., Powrie, F., & Maloy, K. J. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111453 · Cited by 580
Microbial Ecology along the Gastrointestinal Tract
Hillman, E. T., Lu, H., Yao, T., & Nakatsu, C. H. (2017) · Microbes and environments · doi:10.1264/jsme2.me17017 · Cited by 580
Epithelial crosstalk at the microbiota–mucosal interface
Wells, J. M., Rossi, O., Meijerink, M., & van Baarlen, P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000092107 · Cited by 579
Immunological pathogenesis of inflammatory bowel disease
Lee, S. H., Kwon, J. E., & Cho, M.-L. (2018) · Intestinal Research · doi:10.5217/ir.2018.16.1.26 · Cited by 575
Britton, G. J., Contijoch, E. J., Mogno, I., Vennaro, O. H., Llewellyn, S. R., Ng, R., Li, Z., Mortha, A., Merad, M., Das, A., et al. (2019) · Immunity · doi:10.1016/j.immuni.2018.12.015 · Cited by 549
Adherent-invasive Escherichia coli in inflammatory bowel disease
Palmela, C., Chevarin, C., Xu, Z., Torres, J., Sevrin, G., Hirten, R., Barnich, N., Ng, S. C., & Colombel, J.-F. (2018) · Gut · doi:10.1136/gutjnl-2017-314903 · Cited by 535
Zhao, Y., Chen, F., Wu, W., Sun, M., Bilotta, A. J., Yao, S., Xiao, Y., Huang, X., Eaves-Pyles, T. D., Golovko, G., et al. (2018) · Mucosal Immunology · doi:10.1038/mi.2017.118 · Cited by 515
c-MAF-dependent regulatory T cells mediate immunological tolerance to a gut pathobiont
Xu, M., Pokrovskii, M., Ding, Y., Yi, R., Au, C., Harrison, O. J., Galan, C., Belkaid, Y., Bonneau, R., & Littman, D. R. (2018) · Nature · doi:10.1038/nature25500 · Cited by 498
Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease
Lee, J.-Y., Hall, J. A., Kroehling, L., Wu, L., Najar, T., Nguyen, H. H., Lin, W.-Y., Yeung, S. T., Silva, H. M., Li, D., et al. (2020) · Cell · doi:10.1016/j.cell.2019.11.026 · Cited by 466
Interactions of Intestinal Bacteria with Components of the Intestinal Mucus
Sicard, J.-F., Le Bihan, G., Vogeleer, P., Jacques, M., & Harel, J. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00387 · Cited by 458
Geirnaert, A., Calatayud, M., Grootaert, C., Laukens, D., Devriese, S., Smagghe, G., De Vos, M., Boon, N., & Van de Wiele, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-11734-8 · Cited by 451
Schaubeck, M., Clavel, T., Calasan, J., Lagkouvardos, I., Haange, S. B., Jehmlich, N., Basic, M., Dupont, A., Hornef, M., Bergen, M. V., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-309333 · Cited by 447
AHR in the intestinal microenvironment: safeguarding barrier function
Stockinger, B., Shah, K., & Wincent, E. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00430-8 · Cited by 403
Commensal gut bacteria: mechanisms of immune modulation
Kelly, D., Conway, S., & Aminov, R. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.04.008 · Cited by 393
Ermund, A., Schütte, A., Johansson, M. E. V., Gustafsson, J. K., & Hansson, G. C. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00046.2013 · Cited by 391
Benjamin, J. L., Hedin, C. R. H., Koutsoumpas, A., Ng, S. C., McCarthy, N. E., Hart, A. L., Kamm, M. A., Sanderson, J. D., Knight, S. C., Forbes, A., et al. (2011) · Gut · doi:10.1136/gut.2010.232025 · Cited by 361
Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD
Kudelka, M. R., Stowell, S. R., Cummings, R. D., & Neish, A. S. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0331-7 · Cited by 355
Nakajima, A., Vogelzang, A., Maruya, M., Miyajima, M., Murata, M., Son, A., Kuwahara, T., Tsuruyama, T., Yamada, S., Matsuura, M., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20180427 · Cited by 340
Oxygen as a driver of gut dysbiosis
Rivera-Chávez, F., Lopez, C. A., & Bäumler, A. J. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.09.022 · Cited by 320
Wang, R. X., Lee, J. S., Campbell, E. L., & Colgan, S. P. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1917597117 · Cited by 318
Emerging functions of serum amyloid A in inflammation
Ye, R. D., & Sun, L. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3vmr0315-080r · Cited by 311
Plichta, D. R., Graham, D. B., Subramanian, S., & Xavier, R. J. (2019) · Cell · doi:10.1016/j.cell.2019.07.045 · Cited by 310
The intestinal barrier, an arbitrator turned provocateur in IBD
Mehandru, S., & Colombel, J.-F. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00399-w · Cited by 299
Park, J.-H., Kotani, T., Konno, T., Setiawan, J., Kitamura, Y., Imada, S., Usui, Y., Hatano, N., Shinohara, M., Saito, Y., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0156334 · Cited by 278
Dupraz, L., Magniez, A., Rolhion, N., Richard, M. L., Da Costa, G., Touch, S., Mayeur, C., Planchais, J., Agus, A., Danne, C., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109332 · Cited by 274
Th17 plasticity and its relevance to inflammatory bowel disease
Ueno, A., Jeffery, L., Kobayashi, T., Hibi, T., Ghosh, S., & Jijon, H. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.12.004 · Cited by 266
Highlighting new phylogenetic specificities of Crohnʼs disease microbiota
Mondot, S., Kang, S., Furet, J. P., Aguirre de Carcer, D., McSweeney, C., Morrison, M., Marteau, P., Doré, J., & Leclerc, M. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21436 · Cited by 264
Lee, S., Yun, Y., Kim, S., Lee, E.-J., Chang, Y., Ryu, S., Shin, H., Kim, H.-L., Kim, H.-N., & Lee, J. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7090282 · Cited by 255
The Paneth Cell: The Curator and Defender of the Immature Small Intestine
Lueschow, S. R., & McElroy, S. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00587 · Cited by 251
Implications of the Westernized Diet in the Onset and Progression of IBD
Rizzello, F., Spisni, E., Giovanardi, E., Imbesi, V., Salice, M., Alvisi, P., Valerii, M. C., & Gionchetti, P. (2019) · Nutrients · doi:10.3390/nu11051033 · Cited by 250
Butyrate and the Fine-Tuning of Colonic Homeostasis: Implication for Inflammatory Bowel Diseases
Gasaly, N., Hermoso, M. A., & Gotteland, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063061 · Cited by 240
Zundler, S., Becker, E., Spocinska, M., Slawik, M., Parga-Vidal, L., Stark, R., Wiendl, M., Atreya, R., Rath, T., Leppkes, M., et al. (2019) · Nature Immunology · doi:10.1038/s41590-018-0298-5 · Cited by 239
Host immunoglobulin G selectively identifies pathobionts in pediatric inflammatory bowel diseases
Armstrong, H., Alipour, M., Valcheva, R., Bording-Jorgensen, M., Jovel, J., Zaidi, D., Shah, P., Lou, Y., Ebeling, C., Mason, A. L., et al. (2019) · Microbiome · doi:10.1186/s40168-018-0604-3 · Cited by 228
Proteus spp. as Putative Gastrointestinal Pathogens
Hamilton, A. L., Kamm, M. A., Ng, S. C., & Morrison, M. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00085-17 · Cited by 222
Probiotics in Inflammatory Bowel Disease
Abraham, B. P., & Quigley, E. M. M. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2017.08.003 · Cited by 214
Li, S., Bostick, J. W., Ye, J., Qiu, J., Zhang, B., Urban, J. F., Avram, D., & Zhou, L. (2018) · Immunity · doi:10.1016/j.immuni.2018.09.015 · Cited by 213
Meta-Analysis of the Turnover of Intestinal Epithelia in Preclinical Animal Species and Humans
Darwich, A. S., Aslam, U., Ashcroft, D. M., & Rostami-Hodjegan, A. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.058404 · Cited by 206
Allais, L., Kerckhof, F., Verschuere, S., Bracke, K. R., De Smet, R., Laukens, D., Van den Abbeele, P., De Vos, M., Boon, N., Brusselle, G. G., et al. (2016) · Environmental Microbiology · doi:10.1111/1462-2920.12934 · Cited by 195
Microbiome, Metabolome and Inflammatory Bowel Disease
Ahmed, I., Roy, B., Khan, S., Septer, S., & Umar, S. (2016) · Microorganisms · doi:10.3390/microorganisms4020020 · Cited by 193
The role of oral bacteria in inflammatory bowel disease
Read, E., Curtis, M. A., & Neves, J. F. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00488-4 · Cited by 193
Westernized Diet is the Most Ubiquitous Environmental Factor in Inflammatory Bowel Disease
Chiba, M., Nakane, K., & Komatsu, M. (2019) · The Permanente Journal · doi:10.7812/tpp/18-107 · Cited by 175
Meta-analysis of gut barrier dysfunction in patients with acute pancreatitis
Wu, L. M., Sankaran, S. J., Plank, L. D., Windsor, J. A., & Petrov, M. S. (2014) · British Journal of Surgery · doi:10.1002/bjs.9665 · Cited by 167
Gut barrier dysfunction in the ApcMin/+ mouse model of colon cancer cachexia
Puppa, M. J., White, J. P., Sato, S., Cairns, M., Baynes, J. W., & Carson, J. A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.08.010 · Cited by 160
Microbiota and mucosal defense in IBD: an update
Stange, E. F., & Schroeder, B. O. (2019) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1671822 · Cited by 159
Ng, S. C., Benjamin, J. L., McCarthy, N. E., Hedin, C. R. H., Koutsoumpas, A. L., Plamondon, S., Price, C. L., Hart, A. L., Kamm, M. A., Forbes, A., et al. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21590 · Cited by 151
Ceponis, P. J. M., Botelho, F. M., Richards, C. D., & McKay, D. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003516200 · Cited by 149
He, W., Wang, J., Sheng, J.-Y., Zha, J., Graham, W. V., & Turner, J. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030993 · Cited by 149
Lee, Y. K., Mehrabian, P., Boyajian, S., Wu, W.-L., Selicha, J., Vonderfecht, S. L., & Mazmanian, S. K. (2018) · mSphere · doi:10.1128/msphere.00587-18 · Cited by 146
The role of infection in the aetiology of inflammatory bowel disease
Hansen, R., Thomson, J., El-Omar, E. M., & Hold, G. L. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-009-0191-y · Cited by 143
Perspectives on Current and Novel Treatments for Inflammatory Bowel Disease
Na, S., & Moon, W. (2019) · Gut and Liver · doi:10.5009/gnl19019 · Cited by 139
He, L., Liu, T., Shi, Y., Tian, F., Hu, H., Deb, D. K., Chen, Y., Bissonnette, M., & Li, Y. C. (2017) · Endocrinology · doi:10.1210/en.2017-00748 · Cited by 123
Self-citationFornelos, N., Franzosa, E. A., Bishai, J. D., Annand, J. W., Oka, A., Lloyd‐Price, J., Arthur, T. D., Garner, A., Ávila-Pacheco, J., Haiser, H. J., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-019-0655-7 · Cited by 119
NLRP1 restricts butyrate producing commensals to exacerbate inflammatory bowel disease
Tye, H., Yu, C., Simms, L. A., de Zoete, M. R., Kim, M. L., Zakrzewski, M., Penington, J. S., Harapas, C. R., Souza-Fonseca-Guimarães, F., Wockner, L. F., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06125-0 · Cited by 113
GCMS-based metabolomic study in mice with colitis induced by dextran sulfate sodium
Shiomi, Y., Nishiumi, S., Ooi, M., Hatano, N., Shinohara, M., Yoshie, T., Kondo, Y., Furumatsu, K., Shiomi, H., Kutsumi, H., et al. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21616 · Cited by 111
Interactions of commensal and pathogenic microorganisms with the mucus layer in the colon
Cai, R., Chen, C., Chen, J., Xu, X., Ding, C., & Gu, B. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1735606 · Cited by 110
Sivignon, A., de Vallée, A., Barnich, N., Denizot, J., Darcha, C., Pignède, G., Vandekerckove, P., & Darfeuille–Michaud, A. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000280 · Cited by 109
Advances in nutritional therapy in inflammatory bowel diseases: Review
Wędrychowicz, A., Zając, A., & Tomasik, P. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i3.1045 · Cited by 109
Therapeutic correction of bacterial dysbiosis discovered by molecular techniques
Sartor, R. B. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809363105 · Cited by 104
Influence of Environmental Factors in the Development and Outcomes of Inflammatory Bowel Disease.
Vedamurthy, A., & Ananthakrishnan, A. N. (2019) · Europe PMC (PubMed Central) · Cited by 101
Flagellin-mediated activation of IL-33-ST2 signaling by a pathobiont promotes intestinal fibrosis
Imai, J., Kitamoto, S., Sugihara, K., Nagao-Kitamoto, H., Hayashi, A., Morhardt, T. L., Kuffa, P., Higgins, P. D. R., Barnich, N., & Kamada, N. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0138-4 · Cited by 91
Assessment of mucosal healing in inflammatory bowel disease: review
Dulai, P. S., Levesque, B. G., Feagan, B. G., D’Haens, G., & Sandborn, W. J. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2015.03.1974 · Cited by 89
Qi, Y., Zang, S., Wei, J., Yu, H.-C., Yang, Z., Wu, H., Kang, Y., Tao, H., Yang, M., Jin, L., et al. (2020) · Genomics · doi:10.1016/j.ygeno.2020.09.063 · Cited by 88
Essential immunologic orchestrators of intestinal homeostasis
Zhou, L., & Sonnenberg, G. F. (2018) · Science Immunology · doi:10.1126/sciimmunol.aao1605 · Cited by 76
Zhao, Y., Guo, Q., Zhu, Q., Tan, R. X., Bai, D., Bu, X., Lin, B., Zhao, K., Pan, C., Chen, H., et al. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0177-x · Cited by 76
Gamage, H. K. A. H., Chong, R. W. W., Bucio-Noble, D., Kautto, L., Hardikar, A. A., Ball, M. S., Molloy, M. P., Packer, N. H., & Paulsen, I. T. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1802209 · Cited by 72
Caenepeel, C., Tabib, N. S. S., Vieira‐Silva, S., & Vermeire, S. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16096 · Cited by 71
The effects of diet and gut microbiota on the regulation of intestinal mucin glycosylation
Qu, D., Wang, G., Yu, L., Tian, F., Chen, W., & Zhai, Q. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.117651 · Cited by 70
Lin, Y., Li, B., Yang, X., Liu, T., Shi, T., Deng, B., Zhang, Y., Jia, L., Jiang, Z., & He, R. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0204-y · Cited by 62
Breathless in the Gut: Implications of Luminal O 2 for Microbial Pathogenicity
Kelly, C. J., & Colgan, S. P. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.03.014 · Cited by 52
Inflammation induced ER stress affects absorptive intestinal epithelial cells function and integrity
Chotikatum, S., Naim, H. Y., & El‐Najjar, N. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2017.12.016 · Cited by 50
Advances in the development of new biologics in inflammatory bowel disease
Ungar, B. (2016) · Annals of Gastroenterology · doi:10.20524/aog.2016.0027 · Cited by 49
Bishop, J. L., Roberts, M. E., Beer, J. L., Huang, M., Chehal, M. K., Fan, X. C., Fouser, L. A., L, H., Bacani, J. T. C., & Harder, K. W. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.60 · Cited by 48
Nazareth, N., Magro, F., Machado, E., Ribeiro, T. G., Martinho, A., Rodrigues, P., Alves, R., Macedo, G. N., Grácio, D., Coelho, R., et al. (2015) · Medical Microbiology and Immunology · doi:10.1007/s00430-015-0420-3 · Cited by 47
Duo, L., Wu, T., Ke, Z., Hu, L., Wang, C., Teng, G., Zhang, W., Wang, W., Ge, Q., Yang, Y., et al. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.10.006 · Cited by 42
Dobrzanska, D. A., Lamaudière, M. T. F., Rollason, J., Acton, L., Duncan, M. J., Compton, S., Simms, J., Weedall, G. D., & Morozov, I. Y. (2019) · Microbial Biotechnology · doi:10.1111/1751-7915.13496 · Cited by 38
He, X., Gao, J., Peng, L., Hu, T., Wan, Y., Zhou, M., Zhen, P., & Cao, H. (2020) · Gut · doi:10.1136/gutjnl-2020-322468 · Cited by 33
Spalinger, M. R., Shawki, A., Chatterjee, P., Canale, V., Santos, A. N., Sayoc-Becerra, A., Scharl, M. M., Tremblay, M. L., Borneman, J., & McCole, D. F. (2021) · Gut · doi:10.1136/gutjnl-2020-323636 · Cited by 30
Azimirad, M., Yadegar, A., Aghdaei, H. A., & Kelly, C. R. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz006 · Cited by 29
Not by (Good) Microbes Alone: Towards Immunocommensal Therapies
Leung, C. Y., & Weitz, J. S. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2018.12.006 · Cited by 20
Evolving Therapeutic Strategies in the Inflammatory Bowel Disease
Na, S.-Y., & Moon, W. (2018) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2018.71.2.61 · Cited by 6
Metadata
- Authors
- Chen, Y., Cui, W., Li, X., & Yang, H.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2021-11-11
- Volume
- 12
- Pages
- 761981-761981
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3214658666
- Cited by
- 271
- References
- 123
- FWCI
- 8.72
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.